Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
JAMA Intern Med ; 173(14): 1359-67, 2013 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-23780507

RESUMEN

IMPORTANCE: Clostridium difficile infection (CDI) has been increasingly reported among healthy individuals in the community. Recent data suggest that community-associated CDI represents one-third of all C difficile cases. The epidemiology and potential sources of C difficile in the community are not fully understood. OBJECTIVES: To determine epidemiological and clinical characteristics of community-associated CDI and to explore potential sources of C difficile acquisition in the community. DESIGN AND SETTING: Active population-based and laboratory-based CDI surveillance in 8 US states. PARTICIPANTS: Medical records were reviewed and interviews performed to assess outpatient, household, and food exposures among patients with community-associated CDI (ie, toxin or molecular assay positive for C difficile and no overnight stay in a health care facility within 12 weeks). Molecular characterization of C difficile isolates was performed. Outpatient health care exposure in the prior 12 weeks among patients with community-associated CDI was a priori categorized into the following 3 levels: no exposure, low-level exposure (ie, outpatient visit with physician or dentist), or high-level exposure (ie, surgery, dialysis, emergency or urgent care visit, inpatient care with no overnight stay, or health care personnel with direct patient care). MAIN OUTCOMES AND MEASURES: Prevalence of outpatient health care exposure among patients with community-associated CDI and identification of potential sources of C difficile by level of outpatient health care exposure. RESULTS: Of 984 patients with community-associated CDI, 353 (35.9%) did not receive antibiotics, 177 (18.0%) had no outpatient health care exposure, and 400 (40.7%) had low-level outpatient health care exposure. Thirty-one percent of patients without antibiotic exposure received proton pump inhibitors. Patients having CDI with no or low-level outpatient health care exposure were more likely to be exposed to infants younger than 1 year (P = .04) and to household members with active CDI (P = .05) compared with those having high-level outpatient health care exposure. No association between food exposure or animal exposure and level of outpatient health care exposure was observed. North American pulsed-field gel electrophoresis (NAP) 1 was the most common (21.7%) strain isolated; NAP7 and NAP8 were uncommon (6.7%). CONCLUSIONS AND RELEVANCE: Most patients with community-associated CDI had recent outpatient health care exposure, and up to 36% would not be prevented by reduction of antibiotic use only. Our data support evaluation of additional strategies, including further examination of C difficile transmission in outpatient and household settings and reduction of proton pump inhibitor use.


Asunto(s)
Clostridioides difficile/aislamiento & purificación , Enterocolitis Seudomembranosa/epidemiología , Vigilancia de la Población , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Atención Ambulatoria/estadística & datos numéricos , Antibacterianos/uso terapéutico , Niño , Preescolar , Clostridioides difficile/clasificación , Infecciones Comunitarias Adquiridas/epidemiología , Utilización de Medicamentos/estadística & datos numéricos , Electroforesis en Gel de Campo Pulsado/estadística & datos numéricos , Enterocolitis Seudomembranosa/transmisión , Heces/microbiología , Femenino , Antagonistas de los Receptores H2 de la Histamina/uso terapéutico , Hospitalización/estadística & datos numéricos , Humanos , Inmunosupresores/uso terapéutico , Lactante , Masculino , Persona de Mediana Edad , Tipificación Molecular , Análisis Multivariante , Inhibidores de la Bomba de Protones/uso terapéutico , Estados Unidos/epidemiología , Adulto Joven
2.
Arch Dermatol ; 143(11): 1393-8, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18025363

RESUMEN

OBJECTIVES: To determine the extent and scope of the outbreak of skin eruptions, to identify the causes of the acute skin diseases, to identify risk factors for the conditions, and to reduce the dermatologic morbidity among workers repairing buildings damaged by Hurricane Katrina and Hurricane Rita. DESIGN: Retrospective cohort study. SETTING: Military base in New Orleans, Louisiana. PARTICIPANTS: Civilian construction workers living and working at a New Orleans military base between August 30, 2005, and October 3, 2005. Living conditions were mainly wooden huts and tents with limited sanitation facilities. MAIN OUTCOME MEASURES: Survey of risk factors, physical examination, skin biopsy specimens, and environmental investigation of the occupational and domiciliary exposures. RESULTS: Of 136 workers, 58 reported rash, yielding an attack rate of 42.6%. The following 4 clinical entities were diagnosed among 41 workers who had a physical examination (some had >1 diagnosis): 27 (65.9%) having papular urticaria, 8 (19.5%) having bacterial folliculitis, 6 (14.6%) having fiberglass dermatitis, and 2 (4.9%) having brachioradial photodermatitis. All diagnoses except brachioradial photodermatitis were confirmed by histopathologic examination. After adjusting for race/ethnicity and occupation, sleeping in previously flooded huts was statistically significantly (adjusted odds ratio, 20.4; 95% confidence interval, 5.9-70.2) associated with developing papular urticaria, the most common cause of rash in this cluster. CONCLUSIONS: We identified 4 distinct clinical entities, although most workers were diagnosed as having papular urticaria. Huts previously flooded as a result of the hurricanes and used for sleeping may have harbored mites, a likely source of papular urticaria. To reduce the morbidity of hurricane-related skin diseases, we suggest avoiding flooded areas, fumigating with an acaricide, and wearing protective clothing.


Asunto(s)
Materiales de Construcción , Desastres , Brotes de Enfermedades , Enfermedades Profesionales/epidemiología , Sistemas de Socorro , Enfermedades de la Piel/epidemiología , Adulto , Brazo , Infecciones Bacterianas/epidemiología , Estudios de Cohortes , Dermatitis por Contacto/epidemiología , Foliculitis/epidemiología , Foliculitis/microbiología , Vidrio , Humanos , Louisiana , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/patología , Trastornos por Fotosensibilidad/epidemiología , Estudios Retrospectivos , Enfermedades de la Piel/patología , Urticaria/epidemiología
3.
J Infect Dis ; 196(12): 1741-8, 2007 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-18190253

RESUMEN

The flavivirus envelope (E) protein mediates cellular attachment and fusion with host cell membranes and is recognized by virus-neutralizing antibodies. We raised antibodies against a broad range of epitopes by immunizing a horse with recombinant West Nile virus (WNV) E protein. To define epitopes recognized by protective antibodies, we selected, by affinity chromatography, immunoglobulins against immobilized linear peptides derived from parts of the E protein. Immunoglobulins binding 9 different peptides from domains I, II, and III of the E protein neutralized WNV in vitro. This indicates that multiple protective epitopes can be found in the E protein. Immunoglobulins recognizing 3 peptides derived from domains I and II of E protein protected mice against a lethal challenge with WNV. These immunoglobulins recognized the E proteins of related flaviviruses, demonstrating that antibodies targeting specific E protein epitopes could be developed for prevention and treatment of multiple flavivirus infections.


Asunto(s)
Anticuerpos Antivirales/inmunología , Inmunización Pasiva/métodos , Inmunoglobulinas/inmunología , Proteínas del Envoltorio Viral/inmunología , Fiebre del Nilo Occidental/prevención & control , Virus del Nilo Occidental/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antivirales/farmacología , Afinidad de Anticuerpos/inmunología , Chlorocebus aethiops , Drosophila , Epítopos/inmunología , Femenino , Técnica del Anticuerpo Fluorescente/métodos , Caballos , Ratones , Ratones Endogámicos C3H , Datos de Secuencia Molecular , Fragmentos de Péptidos/inmunología , Células Vero , Fiebre del Nilo Occidental/inmunología , Fiebre del Nilo Occidental/virología
4.
J Virol ; 80(22): 11000-8, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16943291

RESUMEN

West Nile virus, a member of the Flavivirus genus, causes fever that can progress to life-threatening encephalitis. The major envelope glycoprotein, E, of these viruses mediates viral attachment and entry by membrane fusion. We have determined the crystal structure of a soluble fragment of West Nile virus E. The structure adopts the same overall fold as that of the E proteins from dengue and tick-borne encephalitis viruses. The conformation of domain II is different from that in other prefusion E structures, however, and resembles the conformation of domain II in postfusion E structures. The epitopes of neutralizing West Nile virus-specific antibodies map to a region of domain III that is exposed on the viral surface and has been implicated in receptor binding. In contrast, we show that certain recombinant therapeutic antibodies, which cross-neutralize West Nile and dengue viruses, bind a peptide from domain I that is exposed only during the membrane fusion transition. By revealing the details of the molecular landscape of the West Nile virus surface, our structure will assist the design of antiviral vaccines and therapeutics.


Asunto(s)
Epítopos , Proteínas del Envoltorio Viral/química , Proteínas del Envoltorio Viral/inmunología , Virus del Nilo Occidental/química , Virus del Nilo Occidental/inmunología , Secuencia de Aminoácidos , Anticuerpos Antivirales/inmunología , Cristalografía por Rayos X , Virus del Dengue/química , Virus de la Encefalitis Transmitidos por Garrapatas/química , Mapeo Epitopo , Modelos Moleculares , Datos de Secuencia Molecular , Unión Proteica , Estructura Terciaria de Proteína , Alineación de Secuencia
5.
Vector Borne Zoonotic Dis ; 2(2): 105-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12653304

RESUMEN

Recombinant West Nile virus envelope (E) protein was examined in enzyme-linked immunosorbent assay (ELISA) to detect antibodies elicited during West Nile virus infection. Horses (nine of 10) and humans (six of six) with confirmed West Nile virus infection had IgG and/or IgM antibodies to the E protein. Antibodies to the recombinant West Nile virus membrane and nonstructural 1 proteins were not detected in any of these sera. An E protein-based ELISA may aid in the serological diagnosis of West Nile virus infection.


Asunto(s)
Ensayo de Inmunoadsorción Enzimática/métodos , Proteínas del Envoltorio Viral/inmunología , Fiebre del Nilo Occidental/diagnóstico , Fiebre del Nilo Occidental/virología , Virus del Nilo Occidental/inmunología , Virus del Nilo Occidental/aislamiento & purificación , Animales , Anticuerpos Antivirales/sangre , Caballos/inmunología , Caballos/virología , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Proteínas Recombinantes/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA